Despite the importance of LTβR signaling in immune homeostasis and tumorigenesis, the precise molecular mechanisms that regulate LTβR signaling, including activation of the canonical and non-canonical NF-κB signaling pathways and how they respectively impact the LTβR-derived tumor-promoting chemo-/cytokine production, remain largely unknown. The gene discussed is LTBR; the disease is neoplasm.